SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 485 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,751,599 | +10.5% | 27,111 | +0.2% | 0.02% | +8.7% |
| Q2 2023 | $5,206,235 | +0.1% | 27,051 | +5.3% | 0.02% | -8.0% |
| Q1 2023 | $5,200,239 | +71.0% | 25,684 | +8.5% | 0.02% | +56.2% |
| Q4 2022 | $3,041,061 | -10.5% | 23,664 | -4.7% | 0.02% | -20.0% |
| Q3 2022 | $3,398,000 | -14.3% | 24,835 | +10.8% | 0.02% | -13.0% |
| Q2 2022 | $3,965,000 | +29.5% | 22,408 | +5.5% | 0.02% | +53.3% |
| Q1 2022 | $3,061,000 | -14.1% | 21,248 | -7.8% | 0.02% | -11.8% |
| Q4 2021 | $3,562,000 | -47.9% | 23,040 | -42.8% | 0.02% | -54.1% |
| Q3 2021 | $6,839,000 | +8.1% | 40,275 | +0.5% | 0.04% | +5.7% |
| Q2 2021 | $6,324,000 | +16.7% | 40,055 | +2.7% | 0.04% | +9.4% |
| Q1 2021 | $5,417,000 | -11.9% | 39,007 | +11.1% | 0.03% | -13.5% |
| Q4 2020 | $6,148,000 | – | 35,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |